Ganglioneuroblastoma Clinical Trials

16 clinical trials for Ganglioneuroblastoma across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase II Study of Proton Radiation Therapy for Neuroblastoma — RECRUITING · NA
• Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma — RECRUITING · PHASE1
• Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) — RECRUITING · PHASE3
• Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma — RECRUITING · PHASE3
• SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours — RECRUITING · NA
• Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification — RECRUITING
• Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma — RECRUITING · PHASE3
• Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma — COMPLETED
• Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma — NOT_YET_RECRUITING · PHASE2
• Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma — COMPLETED · PHASE2
• Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 — ACTIVE_NOT_RECRUITING · PHASE1
• Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma — ACTIVE_NOT_RECRUITING · PHASE3
• An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin — COMPLETED · PHASE1
• Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma — COMPLETED · PHASE1
• Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma — COMPLETED · PHASE2

Refine this search